Atlas Trials

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

Clinical trial NCT03727633 · TERMINATED

Trial details

NCT number
NCT03727633
Sponsor
University Hospital, Montpellier
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2018-07-19
Primary completion
2025-06-18
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.